Improving survival from metastatic, recurrent, or persistent cervical cancer. | Lancet;403(10421): 2-4, 2024 Jan 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Improving survival from metastatic, recurrent, or persistent cervical cancer.

Mileshkin, Linda R; Manoharan, Sathya.

Affiliation

Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia. Electronic address: linda.mileshkin@petermac.org.
Manoharan S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne and University of Melbourne, Melbourne, VIC 3000, Australia.

Lancet ; 403(10421): 2-4, 2024 Jan 06.

Article in En | MEDLINE | ID: mdl-38048788

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Lancet Year: 2024 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Lancet Year: 2024 Document type: Article